| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.61B | 49.16B | 44.10B | 39.66B | 38.85B | 37.87B |
| Gross Profit | 13.73B | 13.54B | 11.70B | 9.95B | 10.24B | 9.96B |
| EBITDA | 3.45B | 3.94B | 2.99B | 2.02B | 2.81B | 2.98B |
| Net Income | 1.61B | 2.01B | 1.31B | 1.02B | 1.65B | 2.08B |
Balance Sheet | ||||||
| Total Assets | 63.12B | 63.73B | 62.23B | 52.13B | 52.08B | 48.70B |
| Cash, Cash Equivalents and Short-Term Investments | 14.69B | 14.04B | 15.55B | 10.32B | 12.44B | 12.49B |
| Total Debt | 10.19B | 10.28B | 10.72B | 5.78B | 3.82B | 2.50B |
| Total Liabilities | 29.25B | 29.16B | 29.14B | 20.52B | 20.03B | 17.24B |
| Stockholders Equity | 33.83B | 34.55B | 33.03B | 31.64B | 32.00B | 31.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 76.00M | 2.01B | -3.82B | 527.00M | 370.00M |
| Operating Cash Flow | 0.00 | 2.99B | 4.33B | -1.64B | 2.22B | 2.78B |
| Investing Cash Flow | 0.00 | -2.81B | -2.33B | -1.23B | -2.17B | -1.87B |
| Financing Cash Flow | 0.00 | -1.75B | 3.19B | 710.00M | -282.00M | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥30.62B | 26.01 | ― | 4.26% | -4.23% | -1.63% | |
73 Outperform | ¥297.56B | 12.67 | ― | 2.99% | 0.31% | -11.04% | |
70 Outperform | ¥86.64B | 15.03 | ― | 4.79% | 1.68% | 18.85% | |
68 Neutral | ¥10.52B | 151.50 | ― | 3.58% | ― | ― | |
65 Neutral | ¥2.94T | 13.56 | 7.55% | 2.22% | -3.22% | -29.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥36.65B | 15.26 | ― | 1.56% | 10.90% | ― |